StockData
Boston Scientific Corp logo

Boston Scientific Corp (BSX) stock

BSXNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 2, 2026Score 14/3048% below fair value
$43.03−0.66 (-1.51%)

Close on Nov 17, 2026Market cap $62.36BP/E 17.4Yield –

Boston Scientific pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Boston Scientific's pe ratio was 18.3× on Nov 11, 2026, against 54.3× a year earlier. Over the last 5 years it ranged from 17.0× to 115.8×, with a median of 68.2×.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202618.3×−32.7
2025Dec 31, 202551.0×−22.8
2024Dec 31, 202473.8×+3.3
2023Dec 29, 202370.5×−39.7
2022Dec 30, 2022110.2×+55.0
2021Dec 31, 202155.2×+41.4
2020Dec 31, 202013.8×–

More Boston Scientific figures

See a number that looks wrong?